United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - treosulfan - powder for solution for injection - 5gram

Ireland - English - HPRA (Health Products Regulatory Authority)

hope pharmaceuticals ltd - sodium thiosulfate - solution for injection - 250 milligram(s)/millilitre - antidotes; thiosulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

medac gesellschaft fur klinische spezialpraparate - treosulfan - capsule - 250 mg milligram

United States - English - NLM (National Library of Medicine)

patterson veterinary - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm), sodium thiosulfate (unii: hx1032v43m) (thiosulfate ion - unii:llt6xv39py), salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz), phytosphingosine hydrochloride (unii: tt871xv7tu) (phytosphingosine - unii:gin46u9q2q) - benzoyl peroxide 30 mg in 1 ml - indications: for use on dogs and cats only. for the management of skin infections and seborrheic disorders. directions for use: wet the animal with cool water and massage the shampoo first on the areas with skin abnormalities, then on the rest of the body. leave the shampoo on for 10 minutes then rinse with cool water. use 2-3 times per week until symptoms subside or as directed by your veterinarian.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - treosulfan, quantity: 5 g - solution, powder for - excipient ingredients: - adults with acute myeloid leukaemia (aml) or myelodysplastic syndrome (mds) trecondi (treosulfan) is indicated in combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation (allohsct) in adult patients with aml or mds at increased risk for standard conditioning therapies.,paediatric patients aged 1 month and older with malignant and non-malignant haematological diseases trecondi (treosulfan) is indicated in combination with fludarabine, with or without thiotepa, as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in paediatric patients older than one month with malignant and non-malignant diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - treosulfan, quantity: 1 g - solution, powder for - excipient ingredients: - adults with acute myeloid leukaemia (aml) or myelodysplastic syndrome (mds) trecondi (treosulfan) is indicated in combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation (allohsct) in adult patients with aml or mds at increased risk for standard conditioning therapies.,paediatric patients aged 1 month and older with malignant and non-malignant haematological diseases trecondi (treosulfan) is indicated in combination with fludarabine, with or without thiotepa, as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in paediatric patients older than one month with malignant and non-malignant diseases.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - sodium thiosulfate+sodium nitrite - antidote

Canada - English - Health Canada

medexus inc - treosulfan - powder - 1g - treosulfan 1g - antineoplastic agents

Canada - English - Health Canada

medexus pharmaceuticals inc. - treosulfan - powder - 5g - treosulfan 5g - antineoplastic agents

Philippines - English - FDA (Food And Drug Administration)

ceva animal health (philippines), inc. - sodium chloride , sodium thiosulfate , sodium bicarbonate (vet.) - powder for oral solution - formulation: each 10 g contains: sodium chloride .............................4.768 g sodium thiosulfate ................................1.52 g sodium bicarbonate ........................... 950 mg carrier .......................................... qs.ad.